Note: Ingredients listed on restricted chemical lists
EC/CAS
203-473-3/107-21-1
Name of the chemical
Ethane-1,2-diol
Concentration
≥50<54
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
0.9 - 1
EC/CAS
205-743-6/149-57-5
Name of the chemical
2-ethylhexanoic acid
Concentration
≥0.15<0.2
General Information
Version
1.1
Revision date
2024-04-06
Product name
Eni Antifreeze Bike S
1.2.1 Relevant identified uses
Industrial use,Professional use,Consumer use Industrial/Professional use spec Wide dispersive use Used in closed systems
supplier name
Application Engineering & Product Management (AEPM)
Emergency telephone
+39 0382 24444
Icons in SDS
Company Information
company name
Enilive Schmiertechnik GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
SDS.Enilive@enilive.com, technik.wuerzburg@enilive.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H315, H319, H373
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP)] Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
Harmful if swallowed. May cause damage to organs (kidneys) through prolonged or repeated exposure (oral). For specific information about the toxicological/ecotoxicological properties and classification of this product, see Sect. 11 and/or Sect. 12
Hazard pictograms
GHS07 GHS08
Signal word
Warning
Contains
ethylene glycol
Hazard statements
H302 - Harmful if swallowed. H315 - Causes skin irritation. H319 - Causes serious eye irritation. H373 - May cause damage to organs (kidneys) through prolonged or repeated exposure (oral).
Precautionary statements
P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P264 - Wash hands thoroughly after handling. P280 - Wear protective clothing, eye protection, face protection, protective gloves. P305+P351+P338+P310 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER, a doctor. P501 - Dispose of contents and container to according to national or local regulations. 2.3. Other hazards (not relevant for classification)
Other hazards which do not result in classification
Any substance, in case of accidents involving pressurized circuits and the like, may be accidentally injected under the skin, even without external damage. In such a case, the victim should be brought to an hospital as soon as possible, to get specialized medical treatment. Do not wait for symptoms to develop. This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH ethylene glycol (107-21-1), 2-ethylhexanoic acid and its salts, with the exception of those regulation, in accordance with Annex XIII specified elsewhere in this Annex (149-57-5), Methyl-1H-benzotriazole (29385-43-1), Sodium hydroxide (1310-73-2) Substance(s) not meeting the vPvB criteria of REACH ethylene glycol (107-21-1), 2-ethylhexanoic acid and its salts, with the exception of those regulation, in accordance with Annex XIII specified elsewhere in this Annex (149-57-5), Methyl-1H-benzotriazole (29385-43-1), Sodium hydroxide (1310-73-2) The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Substance(s) not included in the list established in ethylene glycol (107-21-1), Sodium hydroxide (1310-73-2), 2-ethylhexanoic acid and its accordance with Article 59(1) of REACH for having salts, with the exception of those specified elsewhere in this Annex (149-57-5), Methyl-1H- endocrine disrupting properties, or is not identified as benzotriazole (29385-43-1) having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
Further information
The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [EU-GHS / CLP] Acute toxicity (oral), Category 4 H302 Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Specific target organ toxicity – Repeated exposure, Category 2 H373 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects Harmful if swallowed. May cause damage to organs (kidneys) through prolonged or repeated exposure (oral). For specific information about the toxicological/ecotoxicological properties and classification of this product, see Sect. 11 and/or Sect. 12.